Investor profile
20/20 HealthCare Partners LLC
VC
See how your deck fits this investor's thesis, stage, and ticket size.
Analyse your fitInvestment thesis
20/20 HealthCare Partners LLC is a Global Investment Group that invests at the early stage of technology & life science innovation. The firm focuses on early round (and follow on) investing in next generation life sciences development entities, specifically once proof of concept has been established. They provide funding for program development post proof of concept through to the successful completion of Verification and Validation studies (pre-regulatory approvals and pre-commercialization). The firm looks for companies in the fields of Diagnostic Imaging, Medical devices, Healthcare IT, Biotechnology & pharmaceuticals. They bring more than just investment capital, employing a flexible structure to address market opportunities, with a strong focus on markets where their experience, knowledge, and network can build companies' value within the Life Sciences industry. Their investments are structured on a transaction-by-transaction basis with high net worth individuals and family offices, targeting returns in the 3-7x range with a typical investment period of 2-3 years to exit.
Notable quotes
“Through our partnering with Roche, we hope to identify scientific innovations that could lead to novel treatments for patients, thus contributing to better management of serious disease conditions. There is significant innovation coming from academia and other research organizations, and we can provide the experience of successfully moving along start-up companies and the capital resources necessary to help advance breakthrough treatments.”
Team
Len Singer
Financial & Structuring Director
Ronny Vinasco Bachrach
Marketing Director
Jonathan Fleming
Advisory Board
Dr. Zafrira Avnur
Advisory Board
Vito Levi D'Ancona
Advisory Board
Recent investments
| Company | Round | Size | Date |
|---|---|---|---|
| Variantyx | Series C | $42m | 2022-02-14 |
| XRHealth | Series B - II | $6m | 2024-01-09 |
| Variantyx | Series C | $20m | 2021-03-15 |
| XRHealth | Series B | $10m | 2022-02-28 |
| NEMDX | unknown | — | — |
| Remedy Plan Therapeutics | unknown | — | — |
| Coagulo Medical Technologies | unknown | — | — |
| Enclear Therapies | unknown | — | — |
| Verseau Therapeutics | unknown | — | — |
| physIQ | unknown | — | — |
Frequent co-investors
| VC firm | Deals together |
|---|---|
| New Era Capital Partners | 3 |
| Pitango HealthTech | 3 |
| Robert Bosch Venture Capital | 2 |
| Peregrine Ventures | 1 |
| IBM Ventures | 1 |
| GHS Fund | 1 |
Fit check
Is 20/20 HealthCare Partners LLC a match for your startup?
Upload your deck and get an instant AI-powered fit analysis — see exactly how your startup aligns with this investor's thesis, stage focus, and ticket size.
Analyse your fit